A congenital heart disease center run by UCLA has just become the first nationally accredited center of its kind in Los Angeles, and the 11th in the U.S.
The Graham-Cassidy health care bill to repeal the Affordable Care Act could strip an estimated 2 million residents in Los Angeles County of their health insurance, according to a UC Berkeley study.
ImaginAb Inc., an Inglewood biotech firm that develops molecular imaging for cancer immunotherapy, has raised nearly $8 million in new capital, according to a recent Securities and Exchange Commission filing.
Cedars-Sinai Medical Center has welcomed 10 new startups to third iteration of its business incubator, the health care outfit announced Tuesday.
Kaiser Permanente turned to Harvard for the chief of its new medical school.
A $5 million gift from a foundation associated with Forest Lawn Memorial-Parks & Mortuaries will help the Braille Institute of America offer free low-vision assistance across Southern California.
People with paraplegia may someday be able to hit their stride in a so-called bionic suit thanks to an $8 million federal research grant to three Southern California universities, officials announced Wednesday.
A new Kaiser Permanente School of Medicine in Pasadena has named an international leader in child, adolescent and family health to be its first chief executive and founding dean, Kaiser officials announced Tuesday.
Scientists at UCLA have launched the first genetically engineered blood stem cell clinical trial to fight cancer thanks to $20 million in voter-approved funds earmarked for stem cell research, university officials announced Monday.
Levine Leichtman Capital Partners, a private equity firm based in Beverly Hills, partnered with management to purchase Capsa Healthcare, a global provider of mobile workstations, medication management tools and pharmacy automation systems, company officials announced Monday.